Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Charleston, SC
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Orangeburg, SC
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Orangeburg, SC
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Austin, TX
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Dallas, TX
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
El Paso, TX
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
El Paso, TX
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
San Antonio, TX
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
San Antonio, TX
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
Waco, TX
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
Waco, TX
Click here to add this to my saved trials
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated:  4/24/2014
GSK Investigational Site
mi
from
South Burlington, VT
A Dose-ranging Study of Fluticasone Furoate (FF)
A Dose-ranging Study of Fluticasone Furoate (FF) Inhalation Powder in Children Aged 5-11 Years With Asthma
Status: Enrolling
Updated: 4/24/2014
GSK Investigational Site
mi
from
South Burlington, VT
Click here to add this to my saved trials
Dose-Response of Salmeterol in Children
Dose-response of Salmeterol Delivered by Advair Diskus in Children: Bioassay by Methacholine Challenge Using Oscillometry as the Endpoint
Status: Enrolling
Updated:  5/8/2014
University of Florida Asthma Research Lab
mi
from
Gainesville, FL
Dose-Response of Salmeterol in Children
Dose-response of Salmeterol Delivered by Advair Diskus in Children: Bioassay by Methacholine Challenge Using Oscillometry as the Endpoint
Status: Enrolling
Updated: 5/8/2014
University of Florida Asthma Research Lab
mi
from
Gainesville, FL
Click here to add this to my saved trials
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated:  5/30/2014
Washington University
mi
from
St. Louis, MO
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated: 5/30/2014
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated:  5/30/2014
Cincinnati Children's Hospital in partnership with University Hospital of Cincinnati
mi
from
Cincinnati, OH
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated: 5/30/2014
Cincinnati Children's Hospital in partnership with University Hospital of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated:  5/30/2014
University of Virginia
mi
from
Charlottesville, VA
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated: 5/30/2014
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults
Assessing the Efficacy of Antipyrine Benzocaine Otic Solution in the Ear Canal to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults.
Status: Enrolling
Updated:  6/2/2014
Augusta University
mi
from
Augusta, GA
Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults
Assessing the Efficacy of Antipyrine Benzocaine Otic Solution in the Ear Canal to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults.
Status: Enrolling
Updated: 6/2/2014
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Do Bonding Disruptions Occur More Often in Children With Asthma Than in Non-asthmatic Populations?
Do Bonding Disruptions Occur More Often in Children With Asthma Than in Non-asthmatic Populations?
Status: Enrolling
Updated:  6/4/2014
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Do Bonding Disruptions Occur More Often in Children With Asthma Than in Non-asthmatic Populations?
Do Bonding Disruptions Occur More Often in Children With Asthma Than in Non-asthmatic Populations?
Status: Enrolling
Updated: 6/4/2014
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Click here to add this to my saved trials
Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Efficacy, Dose-ranging and Safety Evaluation (A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Single Dose, Five-arm, Crossover, and Dose-ranging Study of A006 in Adult Asthma Patients)
Status: Enrolling
Updated:  8/5/2014
Allergy & Asthma Associates of Santa Clara Valley Research Center
mi
from
San Jose, CA
Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Efficacy, Dose-ranging and Safety Evaluation (A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Single Dose, Five-arm, Crossover, and Dose-ranging Study of A006 in Adult Asthma Patients)
Status: Enrolling
Updated: 8/5/2014
Allergy & Asthma Associates of Santa Clara Valley Research Center
mi
from
San Jose, CA
Click here to add this to my saved trials
Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Efficacy, Dose-ranging and Safety Evaluation (A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Single Dose, Five-arm, Crossover, and Dose-ranging Study of A006 in Adult Asthma Patients)
Status: Enrolling
Updated:  8/5/2014
Clinical Research Institute of Southern Oregon, PC
mi
from
Medford, OR
Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Efficacy, Dose-ranging and Safety Evaluation (A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Single Dose, Five-arm, Crossover, and Dose-ranging Study of A006 in Adult Asthma Patients)
Status: Enrolling
Updated: 8/5/2014
Clinical Research Institute of Southern Oregon, PC
mi
from
Medford, OR
Click here to add this to my saved trials
Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Efficacy, Dose-ranging and Safety Evaluation (A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Single Dose, Five-arm, Crossover, and Dose-ranging Study of A006 in Adult Asthma Patients)
Status: Enrolling
Updated:  8/5/2014
Central Texas Health Research
mi
from
New Braunfels, TX
Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Efficacy, Dose-ranging and Safety Evaluation (A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Single Dose, Five-arm, Crossover, and Dose-ranging Study of A006 in Adult Asthma Patients)
Status: Enrolling
Updated: 8/5/2014
Central Texas Health Research
mi
from
New Braunfels, TX
Click here to add this to my saved trials
Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Efficacy, Dose-ranging and Safety Evaluation (A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Single Dose, Five-arm, Crossover, and Dose-ranging Study of A006 in Adult Asthma Patients)
Status: Enrolling
Updated:  8/5/2014
Sylvana Research Associates
mi
from
San Antonio, TX
Albuterol DPI (A006) Clinical Study-B3:Efficacy, Dose-ranging and Safety Evaluation
Efficacy, Dose-ranging and Safety Evaluation (A Randomized, Double- or Evaluator-blinded, Active- and Placebo-controlled, Single Dose, Five-arm, Crossover, and Dose-ranging Study of A006 in Adult Asthma Patients)
Status: Enrolling
Updated: 8/5/2014
Sylvana Research Associates
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
A Phase II/III, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate Safety and Efficacy of Tiotropium Inhalation Solution (2.5 µg and 5 µg) Administered Once Daily in the Afternoon Via Respimat® Inhaler for 12 Weeks in Patients 1 to 5 Years Old With Persistent Asthma
Status: Enrolling
Updated:  8/20/2014
1245.25.10112 Boehringer Ingelheim Investigational Site
mi
from
Columbia, MO
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
A Phase II/III, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate Safety and Efficacy of Tiotropium Inhalation Solution (2.5 µg and 5 µg) Administered Once Daily in the Afternoon Via Respimat® Inhaler for 12 Weeks in Patients 1 to 5 Years Old With Persistent Asthma
Status: Enrolling
Updated: 8/20/2014
1245.25.10112 Boehringer Ingelheim Investigational Site
mi
from
Columbia, MO
Click here to add this to my saved trials
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
A Phase II/III, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate Safety and Efficacy of Tiotropium Inhalation Solution (2.5 µg and 5 µg) Administered Once Daily in the Afternoon Via Respimat® Inhaler for 12 Weeks in Patients 1 to 5 Years Old With Persistent Asthma
Status: Enrolling
Updated:  8/20/2014
Boehringer Ingelheim Investigational Site
mi
from
Oklahoma City, OK
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
A Phase II/III, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate Safety and Efficacy of Tiotropium Inhalation Solution (2.5 µg and 5 µg) Administered Once Daily in the Afternoon Via Respimat® Inhaler for 12 Weeks in Patients 1 to 5 Years Old With Persistent Asthma
Status: Enrolling
Updated: 8/20/2014
Boehringer Ingelheim Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
A Phase II/III, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate Safety and Efficacy of Tiotropium Inhalation Solution (2.5 µg and 5 µg) Administered Once Daily in the Afternoon Via Respimat® Inhaler for 12 Weeks in Patients 1 to 5 Years Old With Persistent Asthma
Status: Enrolling
Updated:  8/20/2014
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
A Phase II/III, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate Safety and Efficacy of Tiotropium Inhalation Solution (2.5 µg and 5 µg) Administered Once Daily in the Afternoon Via Respimat® Inhaler for 12 Weeks in Patients 1 to 5 Years Old With Persistent Asthma
Status: Enrolling
Updated: 8/20/2014
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
A Phase II/III, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate Safety and Efficacy of Tiotropium Inhalation Solution (2.5 µg and 5 µg) Administered Once Daily in the Afternoon Via Respimat® Inhaler for 12 Weeks in Patients 1 to 5 Years Old With Persistent Asthma
Status: Enrolling
Updated:  8/20/2014
205.443.12004 Boehringer Ingelheim Investigational Site
mi
from
Summerville, SC
Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma
A Phase II/III, Randomised, Double-blind, Placebo-controlled, Parallel Group Trial to Evaluate Safety and Efficacy of Tiotropium Inhalation Solution (2.5 µg and 5 µg) Administered Once Daily in the Afternoon Via Respimat® Inhaler for 12 Weeks in Patients 1 to 5 Years Old With Persistent Asthma
Status: Enrolling
Updated: 8/20/2014
205.443.12004 Boehringer Ingelheim Investigational Site
mi
from
Summerville, SC
Click here to add this to my saved trials
Minimally Invasive Biomarker for Asthma Disease Severity
Feasibility of Using an Eosinophil-Specific Biomarker-(Eosinophil Peroxidase) in Clinical Practice
Status: Enrolling
Updated:  8/22/2014
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Minimally Invasive Biomarker for Asthma Disease Severity
Feasibility of Using an Eosinophil-Specific Biomarker-(Eosinophil Peroxidase) in Clinical Practice
Status: Enrolling
Updated: 8/22/2014
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Academic Achievement in Children With Asthma
Academic Achievement in Children With Asthma
Status: Enrolling
Updated:  8/27/2014
Children's National Health Systems
mi
from
Washington,
Academic Achievement in Children With Asthma
Academic Achievement in Children With Asthma
Status: Enrolling
Updated: 8/27/2014
Children's National Health Systems
mi
from
Washington,
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Huntington Beach, CA
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Stockton, CA
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Stockton, CA
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Miami, FL
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Miami Lakes, FL
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Normal, IL
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Normal, IL
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Warrensburg, MO
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Warrensburg, MO
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Bellevue, NE
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Bellevue, NE
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Corning, NY
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Corning, NY
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Raleigh, NC
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Lebanon, TN
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Lebanon, TN
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Arlington, TX
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Boerne, TX
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Boerne, TX
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Dallas, TX
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Dallas, TX
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
San Antonio, TX
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated:  8/28/2014
Clinical Research Facility
mi
from
Waco, TX
A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223)
A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma
Status: Enrolling
Updated: 8/28/2014
Clinical Research Facility
mi
from
Waco, TX
Click here to add this to my saved trials
Physiology Assessment by Bedside Ultrasonography in Children
Primary Physiology Assessment by Bedside Ultrasonography in Children
Status: Enrolling
Updated:  12/2/2014
Kosair Children's Hospital
mi
from
Louisville, KY
Physiology Assessment by Bedside Ultrasonography in Children
Primary Physiology Assessment by Bedside Ultrasonography in Children
Status: Enrolling
Updated: 12/2/2014
Kosair Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated:  1/15/2015
Novartis Investigative Site
mi
from
Mobile, AL
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated: 1/15/2015
Novartis Investigative Site
mi
from
Mobile, AL
Click here to add this to my saved trials
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated:  1/15/2015
Novartis Investigative Site
mi
from
Fresno, CA
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated: 1/15/2015
Novartis Investigative Site
mi
from
Fresno, CA
Click here to add this to my saved trials
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated:  1/15/2015
Novartis Investigative Site
mi
from
Hawaiian Gardens, CA
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated: 1/15/2015
Novartis Investigative Site
mi
from
Hawaiian Gardens, CA
Click here to add this to my saved trials
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated:  1/15/2015
Novartis Investigative Site
mi
from
Riverside, CA
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated: 1/15/2015
Novartis Investigative Site
mi
from
Riverside, CA
Click here to add this to my saved trials
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated:  1/15/2015
Novartis Investigative Site
mi
from
San Jose, CA
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated: 1/15/2015
Novartis Investigative Site
mi
from
San Jose, CA
Click here to add this to my saved trials
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated:  1/15/2015
Novartis Investigative Site
mi
from
Vista, CA
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated: 1/15/2015
Novartis Investigative Site
mi
from
Vista, CA
Click here to add this to my saved trials
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated:  1/15/2015
Novartis Investigative Site
mi
from
Washington,
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated: 1/15/2015
Novartis Investigative Site
mi
from
Washington,
Click here to add this to my saved trials
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated:  1/15/2015
Novartis Investigative Site
mi
from
Lynn Haven, FL
Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma
A Multi-Center, Randomized, Double-Blind, Placebo and Active-Controlled Study With Exploratory DR to Investigate the Efficacy and Safety of 16 Wks Treatment With s.c. QGE031 in Asthma Patients Not Adequately Controlled With High-dose Inhaled Corticosteroids and Long Acting β2-agonists
Status: Enrolling
Updated: 1/15/2015
Novartis Investigative Site
mi
from
Lynn Haven, FL
Click here to add this to my saved trials